Trident Texofab Limited has submitted to exchange Integrated (financial) for the Quarter and Nine months ended on 31.12.2024
Trident Texofab Ltd. Press Release Feb 03 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Trident Texofab
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.12.2024
- Result-Financial Result For The Quarter And Nine Months Ended On 31.12.2024
- Board Meeting Outcome for Outcome Of Board Meeting Held On 03.02.2025
- Trident Texofab Ltd. Press Release Jan 29 2025
- Board Meeting Intimation for Consider And Approve Of Un-Audited Financial Result For The Quarter And Nine Month Ended On 31.12.2024
Later from Trident Texofab
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Trident Texofab Ltd. Press Release Feb 05 2025
- Board Meeting Outcome for Meeting Of The Company Held On Monday, March 17, 2025
- Outcome Of Board Meeting Held On Monday, March 17, 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab